The mean increase in Tregs was 1.84-fold greater in the EphB4 shRNA tumors compared to the controls (Fig. 7a) and consistent with the notion that Tregs are involved in immune evasion, inhibiting an effective anti-tumor immune response. The gene discussed is EPHB4; the disease is neoplasm.